Banner - NPPA Connect
NP/PA Connect
News
Media
Around the PracticeBetween The LinesCase-Based Peer PerspectiveClinical Case CollectiveDermViewExpert PerspectivesFellows Face OffFrontline ForumMedical World NewsPatient PerspectivesPodcastsReadout360Recognize and Refer
Conferences
Conference CoverageConference Listing
Events
Case-Based Roundtable
More
Publication
Dermatology Times
CME/CE
Resources
DermIQInteractive ToolsJob BoardPartner PerspectivesPerspectives in DermatologyPollsSponsored ContentSponsored ResourcesSpot Test
Editorial Advisory Board
Partners

Subscribe

  • NP/PA Connect
  • News
  • Media
  • Conferences
  • Events
  • Publication
  • CME/CE
  • Resources
  • Editorial Advisory Board
  • Partners
  • Subscribe
  • Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
    • Non-Melanoma Skin Cancers
  • Vitiligo
  • Wound Care
Advertisement

Gianna Melendez, MS, Spherix Global Insights

Advertisement

Articles by Gianna Melendez, MS, Spherix Global Insights

Delving Into NP/PA Perspectives on Emerging Atopic Dermatitis Treatment Options

ByLauren Buchanan, MA, Managing Editor,Gianna Melendez, MS, Spherix Global Insights
August 9th 2024

Explore how surveyed providers perceive current and emerging therapies in the atopic dermatitis.

Evaluating the Efficacy and Perception of HS Treatment Options

ByLauren Buchanan, MA, Managing Editor,Gianna Melendez, MS, Spherix Global Insights
July 22nd 2024

Spherix Global Insights recently delved into the efficacy, patient quality of life, and symptom management of adalimumab vs secukinumab.

Advertisement

Latest Updated Articles

  • Delving Into NP/PA Perspectives on Emerging Atopic Dermatitis Treatment Options
    Delving Into NP/​PA Perspectives on Emerging Atopic Dermatitis Treatment Options

    Published: August 9th 2024 | Updated:



Advertisement
Advertisement

Trending on Dermatology Times

1

Icotrokinra Shows Superior Efficacy Over Advanced Oral Therapies in New Psoriasis Meta-Analysis

2

AbbVie Files for Vitiligo Indication, Putting Systemic Therapy Under Regulatory Review

3

Nutrafol Expands Portfolio with First and Only Hair Loss Supplement for Male Patients 50 and Older

4

Introducing Dermatology Times NP/PA Connect

5

FDA Accepts Galderma’s BLA Resubmission for Liquid Neuromodulator RelabotulinumtoxinA

  • About
  • Advertise
  • Contact Us
  • Job Board
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy Policy
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us